DuBois, PA / / September 12, 2025 / Highroad Enterprises Key Takeaways StemWave acoustic wave therapy offers a non-invasive ...
DuBois, PA / / August 27, 2025 / Highroad Enterprises Key Takeaways: Peripheral neuropathy can be a symptom of chronic Lyme ...
Hereditary transthyretin-mediated amyloidosis (hATTR) is a type of amyloidosis, which is a group of diseases where abnormal proteins (amyloids) build up and damage areas of the body. When the amyloids ...
A CRISPR-Cas9-based therapy targeting the gene encoding transthyretin greatly reduced transthyretin levels in patients with ...
Dr. Noah Marchese, owner of HealthChoice Center of Peachtree City, offers a variety of treatment options for patients with peripheral neuropathy - a conditi ...
CARLSBAD, Calif., Dec. 21, 2023 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (IONS) (Nasdaq: IONS) announced today that the U.S. Food and Drug Administration (FDA) has approved Ionis and AstraZeneca's ...
The FDA expanded the indication of efgartigimod alfa and hyaluronidase-qvfc (Vyvgart Hytrulo) Friday to include treatment of adults with chronic inflammatory demyelinating polyneuropathy (CIDP), ...
Diabetic foot is a type of nerve damage that leads to poor circulation, slower healing, and in severe cases, infections that ...
"Our data support the use of sNfL in screening TTRv carriers and in monitoring disease progression and effect of treatment in ATTRv amyloidosis patients…Larger studies are warranted to confirm and ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca and Ionis’ WAINUA™ (eplontersen) has been approved in the US for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback